Charles R. Goulding and Preeti Sulibhavi explain how KKR’s investment in Henry Schein signals a transformative shift in ...

ICICI Securities recommended hold rating on HealthCare Global Enterprises with a target price of Rs 525 in its research ...

The group will purchase up to 54% of HCG’s equity at $5.14 (INR 445) per share. Global investment firm KKR has signed ...

Discover why KKR Real Estate Finance offers value with a 9% dividend yield, 24% discount to book value, and growth-focused ...

HealthCare Global share price has risen by over 2% in the past month and more than 5% on a year-to-date (YTD) basis. The ...

KKR has agreed to acquire a majority stake in Healthcare Global Enterprises, an India-based oncology hospital chain, for $400 million. The seller is CVC Capital Partners. Dr. BS Ajaikumar, founder of ...

Private equity firm KKR has agreed to acquire a controlling stake in oncology hospital chain Healthcare Global ...

India's hospital sector is experiencing a surge in deal-making, with KKR acquiring Healthcare Global for $400 million. This ...

As part of the deal, KKR will purchase up to 54 per cent of HCG's equity from CVC Asia V at a price of INR 445 per share.

US-based investment company KKR has agreed to acquire a stake of up to 54% in Healthcare Global Enterprises (HCG), an ...

BS Ajai Kumar, Executive Chairman of HealthCare Global Enterprises (HCG) sees great potential in partnering with global ...

KKR, a leading global investment firm, and Healthcare Global Enterprises (HCG) have signed a definitive agreements with CVC, a leading global private markets manager, under which funds managed by KKR ...